Caprolactam Chemicals Intrinsic Value
Caprolactam Chemicals intrinsic value. Caprolactam Chemicals (CAPRO) median intrinsic value is ₹14.40 from 8 valuation models (range ₹14–₹37), vs current price ₹47.76 — -69.8% downside (Trading Above Calculated Value), margin of safety -100.0%. Read Caprolactam Chemicals dividend payments for the complete payout history and dividend yield track record.
CAPRO Valuation Methods Summary — DCF, Graham Number & P/E
Caprolactam Chemicals intrinsic value across 8 models vs current price ₹47.76 — upside/downside and value range per method. For current market price and key ratios, visit Caprolactam Chemicals stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹14.33 | ₹11.46 - ₹17.20 | -70.0% | EPS: ₹0.90, Sector P/E: 12x |
| Book Value Method | asset | ₹14.00 | ₹12.60 - ₹15.40 | -70.7% | Book Value/Share: ₹14.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹14.40 | ₹12.96 - ₹15.84 | -69.8% | Revenue/Share: ₹18.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹36.00 | ₹32.40 - ₹39.60 | -24.6% | EBITDA: ₹3.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹37.14 | ₹29.71 - ₹44.57 | -22.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹14.33 | ₹12.90 - ₹15.76 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹14.33 | ₹12.90 - ₹15.76 | -70.0% | Revenue Growth: -2.6%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹16.84 | ₹15.16 - ₹18.52 | -64.7% | EPS: ₹0.90, BVPS: ₹14.00 |
CAPRO Intrinsic Value vs Market Price — All Valuation Models
Caprolactam Chemicals fair value range ₹14–₹37 vs current market price ₹47.76 across 8 valuation models. Compare with CAPRO DCF valuation to assess whether the stock is under or overvalued.
CAPRO Intrinsic Value Analysis — Undervalued or Overvalued?
Caprolactam Chemicals median intrinsic value ₹14.40, current price ₹47.76 — Trading Above Calculated Value by 69.8%, margin of safety -100.0%.
What is the intrinsic value of CAPRO?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Caprolactam Chemicals (CAPRO) is ₹14.40 (median value). With the current market price of ₹47.76, this represents a -69.8% variance from our estimated fair value.
The valuation range spans from ₹14.00 to ₹37.14, indicating ₹14.00 - ₹37.14.
Is CAPRO undervalued or overvalued?
Based on our multi-method analysis, Caprolactam Chemicals (CAPRO) appears to be trading above calculated value by approximately 69.8%.
CAPRO Financial Health — Key Ratios vs Industry Benchmarks
Caprolactam Chemicals financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
CAPRO Cash Flow Quality — Operating & Free Cash Flow
Caprolactam Chemicals operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |